Healthcare AI reports.
Grounded multi-agent synthesis across five healthcare domains.
GOMUS Org delivers tailored intelligence reports for pharmaceutical, medical device, and clinical research teams. Every claim is backed by verifiable evidence from peer-reviewed literature, regulatory databases, and curated knowledge graphs.
Pharmacovigilance
Continuous monitoring of drug safety signals across regulatory databases, clinical literature, and post-market surveillance sources.
What we deliver
- ICSR analysis and signal detection reports
- Periodic safety update reviews (PSUR-aligned)
- Risk management plan support documents
- Literature monitoring digests
Methodology
Our system integrates FAERS, EudraVigilance, OpenFDA, and PubMed sources. Each signal report includes evidence traceable to the case-ID or citation level. Severity scoring is grounded in MedDRA terminology and reviewed against established causality criteria.
Medical Device Vigilance
Post-market surveillance and incident analysis for medical devices under MDR, FDA QSR, and IMDRF frameworks.
What we deliver
- Adverse event landscape reports (FDA MAUDE, MedSun)
- Field safety corrective action tracking
- Regulatory horizon scanning
- Comparative device incident analysis
Methodology
We combine MAUDE database queries, MDR Eudamed records (where accessible), and PubMed clinical literature. Each report identifies emerging safety patterns with full source attribution, mapped to device GMDN codes and IMDRF adverse event codes.
AI-Human Integration
Brain-computer interfaces, neural prosthetics, and adaptive human-AI systems — landscape intelligence and competitive analysis.
What we deliver
- Technology landscape reports (BCI, neural decoding, closed-loop systems)
- Patent freedom-to-operate analyses
- Regulatory pathway summaries (FDA Breakthrough, EU MDR Class III)
- Clinical trial intelligence
Methodology
Our pipeline integrates USPTO/EPO patent records, FDA premarket databases, ClinicalTrials.gov, and peer-reviewed literature. Reports trace each insight back to primary source documents, with structured summaries of clinical endpoints and regulatory milestones.
Longevity
Evidence-based intelligence on aging biomarkers, geroprotective interventions, and clinical longevity research.
What we deliver
- Biomarker landscape and validation status reports
- Intervention efficacy reviews (lifestyle, pharmacological, supplements)
- Clinical trial roundup (longevity-focused studies)
- Mechanistic literature digests
Methodology
The system synthesises PubMed clinical evidence, GenAge database entries, and ClinicalTrials.gov registrations. Each claim is filtered through citation validation to exclude unsupported assertions, with confidence levels grounded in study design and replication.
Drug Repurposing
Identification of repurposing candidates for rare and unmet-need conditions, with full evidence chains and regulatory context.
What we deliver
- Candidate ranking reports per disease
- Evidence packs (literature + knowledge graph + mechanism)
- Regulatory pathway mapping (505(b)(2), supplemental NDA, orphan)
- Competitive landscape (active repurposing programs)
Methodology
We integrate PubMed, the PrimeKG biomedical knowledge graph, ChEMBL pharmacology, and DrugBank pharmaceutical data. Every candidate is scored against multi-source evidence with full provenance tracking, including mechanism-of-action chains and existing clinical trial activity.
Engage with us.
For tailored reports and partnership inquiries:
info@gomus.orgReports are produced on demand. We respond within two business days.